BACKGROUND AND OBJECTIVE: Monitoring health-related quality of life (HRQoL) by using electronic patient-reported outcomes (ePROs) has been only minimally evaluated in pediatrics. Children with juvenile idiopathic arthritis (JIA) are at risk for HRQoL problems. The aim of this study was to investigate the effectiveness of ePROs in clinical pediatric rheumatology care. METHODS: All children (aged 0-18 years) with JIA visiting any of the 4 pediatric rheumatology clinics in Amsterdam between February 2009 and February 2010 were eligible for this sequential cohort intervention study. Before an outpatient consultation, children (aged 8-18 years) or parents (of children aged 0-7 years) completed web-based questionnaires. The resulting ePROfile was provided to the pediatric rheumatologist (PR). The study was divided into a control period in which the ePROfile was not discussed during consultation, and an intervention period in which the ePROfile was provided and discussed during consultation. Effectiveness was evaluated in terms of communication about different HRQoL topics, referral to a psychologist, and satisfaction with the consultations. RESULTS: Out of the eligible JIA patients, 176 (65%) participated in the study. Use of the ePROfile increased discussion of psychosocial topics (P < .01), as well as the PR's satisfaction with provided care during consultation (P < .01). The use of ePROfiles did not affect referrals to a psychologist or parental satisfaction. Parents and PRs evaluated the use of the ePROfile as positive in 80% to 100% of the consultations. CONCLUSIONS: Our web-based application to systemically monitor HRQoL problems in pediatric rheumatology contributed significantly to communication about psychosocial issues in a positive way. We recommend implementation of ePROs in pediatric clinical practice.
BACKGROUND AND OBJECTIVE: Monitoring health-related quality of life (HRQoL) by using electronic patient-reported outcomes (ePROs) has been only minimally evaluated in pediatrics. Children with juvenile idiopathic arthritis (JIA) are at risk for HRQoL problems. The aim of this study was to investigate the effectiveness of ePROs in clinical pediatric rheumatology care. METHODS: All children (aged 0-18 years) with JIA visiting any of the 4 pediatric rheumatology clinics in Amsterdam between February 2009 and February 2010 were eligible for this sequential cohort intervention study. Before an outpatient consultation, children (aged 8-18 years) or parents (of children aged 0-7 years) completed web-based questionnaires. The resulting ePROfile was provided to the pediatric rheumatologist (PR). The study was divided into a control period in which the ePROfile was not discussed during consultation, and an intervention period in which the ePROfile was provided and discussed during consultation. Effectiveness was evaluated in terms of communication about different HRQoL topics, referral to a psychologist, and satisfaction with the consultations. RESULTS: Out of the eligible JIA patients, 176 (65%) participated in the study. Use of the ePROfile increased discussion of psychosocial topics (P < .01), as well as the PR's satisfaction with provided care during consultation (P < .01). The use of ePROfiles did not affect referrals to a psychologist or parental satisfaction. Parents and PRs evaluated the use of the ePROfile as positive in 80% to 100% of the consultations. CONCLUSIONS: Our web-based application to systemically monitor HRQoL problems in pediatric rheumatology contributed significantly to communication about psychosocial issues in a positive way. We recommend implementation of ePROs in pediatric clinical practice.
Authors: Marisa E Hilliard; Maartje De Wit; Rachel M Wasserman; Ashley M Butler; Meredyth Evans; Jill Weissberg-Benchell; Barbara J Anderson Journal: Pediatr Diabetes Date: 2017-09-22 Impact factor: 4.866
Authors: Joanne Wolfe; Liliana Orellana; E Francis Cook; Christina Ullrich; Tammy Kang; Jeffrey Russell Geyer; Chris Feudtner; Jane C Weeks; Veronica Dussel Journal: J Clin Oncol Date: 2014-03-10 Impact factor: 44.544
Authors: Sasja A Schepers; Lotte Haverman; Sima Zadeh; Martha A Grootenhuis; Lori Wiener Journal: Pediatr Blood Cancer Date: 2016-08-11 Impact factor: 3.167
Authors: Kim S Bull; Samantha Hornsey; Colin R Kennedy; Anne-Sophie E Darlington; Martha A Grootenhuis; Darren Hargrave; Christina Liossi; Jonathan P Shepherd; David A Walker; Christopher Morris Journal: Neurooncol Pract Date: 2019-12-08
Authors: Niels Kramer; Sanne L Nijhof; Elise M van de Putte; Marjolijn Ketelaar; Martha A Grootenhuis; Kors van der Ent; Joost F Swart; Martine van Grotel; Geertje W Dalmeijer; Merel M Nap-van der Vlist Journal: BMJ Paediatr Open Date: 2021-05-21
Authors: Maud M van Muilekom; Michiel A J Luijten; Hedy A van Oers; Caroline B Terwee; Raphaële R L van Litsenburg; Leo D Roorda; Martha A Grootenhuis; Lotte Haverman Journal: J Patient Rep Outcomes Date: 2021-07-10
Authors: Perrine F Limperg; Lotte Haverman; Hedy A van Oers; Marion A J van Rossum; Heleen Maurice-Stam; Martha A Grootenhuis Journal: Health Qual Life Outcomes Date: 2014-01-18 Impact factor: 3.186
Authors: Eefje Ja Verhoof; Heleen Maurice-Stam; Hugo Sa Heymans; Andrea Wm Evers; Martha A Grootenhuis Journal: Child Adolesc Psychiatry Ment Health Date: 2014-04-15 Impact factor: 3.033